2009

Martínez Orgado J, Fernández-Ruiz J, Romero J. The endocannabinoid system in neuropathological states. Int Rev Psychiatry 2009;21(2):172-180

Palazuelos J, Aguado T, Pazos MR, Julien B, Carrasco C, Resel E, Sagredo O, Benito C, Romero J, Azcoitia I, Fernández-Ruiz J, Guzmán M, Galve-Roperh I. Microglial CB2 cannabinoid receptors are neuroprotective in Huntington’s disease excitotoxicity. Brain. 2009;132(Pt 11):3152-3164.

Romero J, Martínez Orgado J. Cannabinoids and neurodegenerative diseases. CNS Neurol Disord Drug Targets. 2009;8(6):440-450

Tolón RM, Núñez E, Pazos MR, Benito C, Castillo AI, Martínez-Orgado JA,Romero J. The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages. Brain Res 2009;1283:148-154.

Sagredo O, González S, Aroyo I, Pazos MR, Benito C, Lastres-Becker I, Romero JP, Tolón RM, Mechoulam R, Brouillet E, Romero J, Fernández-Ruiz J. Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington’s disease. Glia 2009;57(11):1154-1167.

Martínez-Orgado J. Perinatal asphyxia: new strategies for neuroprotection. J Perinat Med 2009;37 (S1):111–113